Li Kang Biomedical Co Stock

Li Kang Biomedical Co EBIT

The EBIT of Li Kang Biomedical Co (6242.TWO) as of Aug 8, 2026 is 98.28 M TWD. In the previous year, EBIT was 90.02 M TWD — a change of 9.18% (higher).

EBIT

98.28 MTWD

YoY

9.18%

Last updated:

In 2026, Li Kang Biomedical Co's EBIT was 98.28 M TWD, a 9.18% increase from the 90.02 M TWD EBIT recorded in the previous year.

The Li Kang Biomedical Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M TWD)
Date
EBIT (M TWD)
Jan 1, 2018
91.00 base
Jan 1, 2019
88.31 base
Jan 1, 2020
87.49 base
Jan 1, 2021
63.94 base
Jan 1, 2022
141.09 base
Jan 1, 2023
139.76 base
Jan 1, 2024
90.02 base
Jan 1, 2025
98.28 base
YEAREBIT (M TWD)
2025 98.28
2024 90.02
2023 139.76
2022 141.09
2021 63.94
2020 87.49
2019 88.31
2018 91.00
2017 84.73
2016 66.59
2015 52.99
2014 7.03
2013 -
2012 -
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
Access this data via the Eulerpool API

Li Kang Biomedical Co Revenue

Li Kang Biomedical Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
495.57 M TWD
91.00 M TWD
76.74 M TWD
Jan 1, 2019
483.30 M TWD
88.31 M TWD
72.02 M TWD
Jan 1, 2020
456.72 M TWD
87.49 M TWD
69.27 M TWD
Jan 1, 2021
386.97 M TWD
63.94 M TWD
51.44 M TWD
Jan 1, 2022
684.25 M TWD
141.09 M TWD
112.09 M TWD
Jan 1, 2023
629.38 M TWD
139.76 M TWD
110.99 M TWD
Jan 1, 2024
565.52 M TWD
90.02 M TWD
77.02 M TWD
Jan 1, 2025
589.21 M TWD
98.28 M TWD
83.82 M TWD

Li Kang Biomedical Co Margins

Li Kang Biomedical Co stock margins

The Li Kang Biomedical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Li Kang Biomedical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Li Kang Biomedical Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
68.50 %
18.36 %
15.48 %
Jan 1, 2019
68.91 %
18.27 %
14.90 %
Jan 1, 2020
65.82 %
19.16 %
15.17 %
Jan 1, 2021
68.40 %
16.52 %
13.29 %
Jan 1, 2022
56.79 %
20.62 %
16.38 %
Jan 1, 2023
67.71 %
22.21 %
17.64 %
Jan 1, 2024
68.27 %
15.92 %
13.62 %
Jan 1, 2025
67.59 %
16.68 %
14.23 %

Li Kang Biomedical Co Stock analysis

What does Li Kang Biomedical Co do? Li Kang Biomedical Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Li Kang Biomedical Co's EBIT

Li Kang Biomedical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Li Kang Biomedical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Li Kang Biomedical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Li Kang Biomedical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Li Kang Biomedical Co stock

EBIT of Li Kang Biomedical Co is 98.28 M TWD in 2026.

EBIT of Li Kang Biomedical Co changed from 90.02 M TWD to 98.28 M TWD, representing a 9.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Li Kang Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Li Kang Biomedical Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Li Kang Biomedical Co

All Key Metrics — Li Kang Biomedical Co